Glibenclamide vs acarbose ‐ neonatal outcomes
Large‐for‐gestational age · women with gestational diabetes mellitus
Glibenclamide showed no clear difference in large‐for‐gestational age compared with acarbose ‐ neonatal outcomes (low certainty).
1 finding from 1 review
- Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes 2017 · Cochrane Headline outcomes onlyRR 2.38 [0.54, 10.46]1 study · 43 participantsLow